Moses 2.0 vs Magneto for HoLEP - a Randomized Controlled Trial
NCT07632742
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The objective of this study is to compare the Magneto 150 holmium laser to the current MOSES 2.0 technology to see if there is a benefit in decreased hemostasis time intraoperatively.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Enlarged Prostate (BPH)
- Benign Prostatic Hyperplasia
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 18 to 100 years
- Sex
- Male
- Healthy volunteers
- Accepted
- Sponsor
- Northwestern University
- Last updated on ClinicalTrials.gov
- October 15, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Illinois · 1
- Northwestern University · Chicago, IL
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.